Holdings (Monthly)
Guide ↗
Select Pharmaceuticals Portfolio
· Fidelity Select Portfolios| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ELI LILLY and CO | 532457108 | Feb 2026 | 390,801 | +28,000 | $431.8M | +13.1% | 28.78% | EC |
| 2 | GSK PLC | 37733W204 | Feb 2026 | 2,425,160 | -156,200 | $122.6M | -19.7% | 8.17% | EC |
| 3 | VIATRIS INC | 92556V106 | Feb 2026 | 5,032,300 | +3,302,700 | $81.8M | +216.9% | 5.45% | EC |
| 4 | UCB SA | N/A | Feb 2026 | 260,100 | -72,758 | $76.4M | +1332.0% | 5.09% | EC |
| 5 | MERCK and CO INC | 58933Y105 | Feb 2026 | 599,336 | +37,800 | $71.2M | +2.3% | 4.74% | EC |
| 6 | ROCHE HOLDING AG | N/A | Feb 2026 | 161,630 | NEW | $68.2M | — | 4.54% | EC |
| 7 | LEGEND BIOTECH CORP | 52490G102 | Feb 2026 | 2,504,500 | -93,900 | $68.0M | +37.8% | 4.53% | EC |
| 8 | ASTRAZENECA PLC | N/A | Feb 2026 | 341,350 | NEW | $63.4M | — | 4.22% | EC |
| 9 | ELANCO ANIMAL HEALTH INC | 28414H103 | Feb 2026 | 2,611,000 | +74,800 | $62.3M | -7.0% | 4.15% | EC |
| 10 | JAZZ PHARMACEUTICALS PLC | N/A | Feb 2026 | 259,600 | NEW | $61.4M | — | 4.09% | EC |
| 11 | GILEAD SCIENCES INC | 375558103 | Feb 2026 | 442,800 | -29,700 | $59.5M | -15.4% | 3.97% | EC |
| 12 | JOHNSON and JOHNSON | 478160104 | Feb 2026 | 251,200 | -208,500 | $56.6M | -50.4% | 3.77% | EC |
| 13 | ROYALTY PHARMA PLC | N/A | Feb 2026 | 718,900 | NEW | $40.1M | — | 2.67% | EC |
| 14 | Fidelity Revere Street Trust | 31635A303 | Feb 2026 | 36,651,092 | -27,877,819 | $36.7M | -43.2% | 2.44% | STIV |
| 15 | MODERNA INC | 60770K107 | Feb 2026 | 499,200 | -189,600 | $23.6M | -36.2% | 1.57% | EC |
| 16 | INTELLIA THERAPEUTICS INC | 45826J105 | Feb 2026 | 1,266,200 | +881,700 | $17.8M | +236.2% | 1.19% | EC |
| 17 | BEAM THERAPEUTICS INC | 07373V105 | Feb 2026 | 500,600 | +85,200 | $16.5M | +39.4% | 1.10% | EC |
| 18 | AXSOME THERAPEUTICS INC | 05464T104 | Feb 2026 | 69,000 | +20,100 | $16.2M | +101.9% | 1.08% | EC |
| 19 | BIONTECH SE | 09075V102 | Feb 2026 | 163,253 | +30,600 | $15.7M | +7.1% | 1.04% | EC |
| 20 | XENON PHARMACEUTICALS INC | 98420N105 | Feb 2026 | 226,000 | -42,600 | $12.4M | +6.5% | 0.82% | EC |
| 21 | OCULAR THERAPEUTIX INC | 67576A100 | Feb 2026 | 1,331,717 | — | $12.0M | +0.8% | 0.80% | EC |
| 22 | IDEXX LABORATORIES INC | 45168D104 | May 2026 | 16,200 | NEW | $9.1M | — | 0.61% | EC |
| 23 | SWEDISH ORPHAN BIOVITRUM AB | N/A | Feb 2026 | 170,200 | NEW | $8.2M | — | 0.54% | EC |
| 24 | PTC THERAPEUTICS INC | 69366J200 | Feb 2026 | 110,000 | -45,600 | $8.1M | -23.4% | 0.54% | EC |
| 25 | CAPRICOR THERAPEUTICS INC | 14070B309 | Feb 2026 | 231,300 | -158,600 | $6.9M | -36.4% | 0.46% | EC |
| 26 | KYMERA THERAPEUTICS INC | 501575104 | Feb 2026 | 84,500 | -17,500 | $6.9M | -26.2% | 0.46% | EC |
| 27 | RAIA DROGASIL SA | N/A | Feb 2026 | 1,691,900 | NEW | $6.3M | — | 0.42% | EC |
| 28 | ANNEXON INC | 03589W102 | Feb 2026 | 1,003,800 | -260,300 | $5.4M | -23.1% | 0.36% | EC |
| 29 | ARROWHEAD PHARMACEUTICALS INC | 04280A100 | Feb 2026 | 65,400 | — | $5.1M | +23.1% | 0.34% | EC |
| 30 | HARMONY BIOSCIENCES HOLDINGS INC | 413197104 | Feb 2026 | 158,577 | — | $5.0M | +10.7% | 0.33% | EC |
| 31 | SERIF BIOMEDICINES, INC | N/A | Feb 2026 | 1,886,792 | NEW | $5.0M | — | 0.33% | EP |
| 32 | CRINETICS PHARMACEUTICALS INC | 22663K107 | Feb 2026 | 131,498 | +8,698 | $4.7M | -7.4% | 0.31% | EC |
| 33 | DEFINIUM THERAPEUTICS INC | 24477V105 | Feb 2026 | 188,000 | — | $4.5M | +38.6% | 0.30% | EC |
| 34 | CORCEPT THERAPEUTICS INC | 218352102 | Feb 2026 | 62,300 | -95,800 | $4.3M | -23.3% | 0.29% | EC |
| 35 | UNIQURE N.V. | N/A | Feb 2026 | 147,178 | NEW | $4.2M | — | 0.28% | EC |
| 36 | ASCENDIS PHARMA A/S | N/A | Feb 2026 | 18,300 | NEW | $4.1M | — | 0.27% | EC |
| 37 | AGOMAB THERAPEUTICS SA | N/A | Feb 2026 | 332,858 | NEW | $3.7M | — | 0.25% | EC |
| 38 | DISC MEDICINE INC | 254604101 | Feb 2026 | 53,800 | — | $3.7M | +4.4% | 0.25% | EC |
| 39 | AMYLYX PHARMACEUTICALS INC | 03237H101 | Feb 2026 | 257,800 | — | $3.7M | -5.4% | 0.25% | EC |
| 40 | PHIBRO ANIMAL HEALTH CORP | 71742Q106 | Feb 2026 | 99,800 | -50,955 | $3.1M | -62.7% | 0.20% | EC |
| 41 | IONIS PHARMACEUTICALS INC | 462222100 | Feb 2026 | 40,100 | +40,000 | $3.1M | +37702.2% | 0.20% | EC |
| 42 | EDGEWISE THERAPEUTICS INC | 28036F105 | Feb 2026 | 83,600 | — | $2.9M | +12.2% | 0.19% | EC |
| 43 | Fidelity Revere Street Trust | 31635A105 | Feb 2026 | 2,589,273 | -2,220,111 | $2.6M | -46.2% | 0.17% | STIV |
| 44 | PARAGON BIOSCIENCES EMALEX CAPITAL INC | N/A | Feb 2026 | 158,879 | NEW | $2.2M | — | 0.15% | EP |
| 45 | CASTLE CREEK BIOSCIENCES INC | N/A | Feb 2026 | 6,308 | NEW | $1.4M | — | 0.09% | EP |
| 46 | EVOZYNE INC | N/A | Feb 2026 | 1,026,017 | NEW | $1.2M | — | 0.08% | DBT |
| 47 | EVOZYNE INC | N/A | Feb 2026 | 56,643 | NEW | $948K | — | 0.06% | EP |
| 48 | PARAGON BIOSCIENCES EMALEX CAPITAL INC | N/A | Feb 2026 | 22,477 | NEW | $311K | — | 0.02% | EP |
| 49 | PARAGON BIOSCIENCES EMALEX CAPITAL INC | N/A | Feb 2026 | 15,977 | NEW | $221K | — | 0.01% | EP |
| 50 | KAILERA THERAPEUTICS INC | 482931102 | May 2026 | 9,000 | NEW | $206K | — | 0.01% | EC |
| 51 | AGOMAB THERAPEUTICS SA | 00860C102 | Feb 2026 | 9,100 | — | $102K | -29.8% | 0.01% | EC |
| 52 | EVOZYNE INC | N/A | Feb 2026 | 5,900 | NEW | $96K | — | 0.01% | EP |
| 53 | PARAGON BIOSCIENCES EMALEX CAPITAL INC | N/A | Feb 2026 | 4,581 | NEW | $63K | — | 0.00% | EP |
| 54 | CASTLE CREEK BIOSCIENCES INC | N/A | Feb 2026 | 200 | NEW | $51K | — | 0.00% | EP |
| 55 | MYOS CORP | N/A | Feb 2026 | 40,000 | NEW | $50K | — | 0.00% | EC |
| 56 | CASTLE CREEK BIOSCIENCES INC | N/A | Feb 2026 | 85 | NEW | $17K | — | 0.00% | EP |
| 57 | MEDAVAIL HOLDINGS INC | N/A | Feb 2026 | 66 | NEW | $0 | — | 0.00% | EC |
| ✕ | BIOGEN INC | 09062X103 | — | 73,000 | SOLD | $14.0M | — | — | — |
| ✕ | ASCENDIS PHARMA A/S | 04351P101 | — | 24,400 | SOLD | $5.7M | — | — | — |
| ✕ | VERA THERAPEUTICS INC | 92337R101 | — | 100,700 | SOLD | $4.1M | — | — | — |
| ✕ | SUMMIT THERAPEUTICS INC | 86627T108 | — | 169,304 | SOLD | $2.8M | — | — | — |
| ✕ | ARRIVENT BIOPHARMA INC | 04272N102 | — | 107,000 | SOLD | $2.5M | — | — | — |
| ✕ | VIKING THERAPEUTICS INC | 92686J106 | — | 64,300 | SOLD | $2.2M | — | — | — |